Your browser doesn't support javascript.
loading
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.
Faisal, Muhammad Salman; Hanel, Walter; Voorhees, Timothy; Li, Rui; Huang, Ying; Khan, Abdullah; Bond, David; Sawalha, Yazeed; Reneau, John; Alinari, Lapo; Baiocchi, Robert; Christian, Beth; Maddocks, Kami; Efebera, Yvonne; Penza, Sam; Saad, Ayman; Brammer, Jonathan; DeLima, Marcos; Jaglowski, Samantha; Epperla, Narendranath.
Afiliación
  • Faisal MS; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Hanel W; Division of Hematology and Medical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Voorhees T; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Li R; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Huang Y; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Khan A; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Bond D; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Sawalha Y; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Reneau J; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Alinari L; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Baiocchi R; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Christian B; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Maddocks K; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Efebera Y; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Penza S; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Saad A; Division of Hematology and Oncology, OhioHealth Bing Cancer Center, Columbus, Ohio, USA.
  • Brammer J; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • DeLima M; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Jaglowski S; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Epperla N; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
Cancer Med ; 12(7): 8228-8237, 2023 04.
Article en En | MEDLINE | ID: mdl-36653918
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article